文献速递骨软组织肉瘤与黑色素瘤

前哨淋巴结对高危皮肤鳞状细胞癌患者无远处转移生存的预后价值

The prognostic value of sentinel lymph nodes on distant metastasis-free survival in patients with high-risk squamous cell carcinoma.
PubMed 文献 · Eur J Cancer · 2019-03-05

该研究为前瞻性招募患者的双向性队列研究,2008年7月至2017年4月对114例高危皮肤鳞状细胞癌患者行前哨淋巴结活检。中位随访23.7个月,多变量分析显示临床隐匿性前哨淋巴结转移与未来远处转移强相关(HR 10.7,95%CI 1.9-60.6),但前哨淋巴结活检阳性患者远处转移的阳性预测值为50%,且7例组织病理学前哨淋巴结阴性患者仍发生远处转移。作者认为前哨淋巴结活检不是评估高危皮肤鳞状细胞癌患者未来系统性播散和远处转移风险的可靠诊断方法。

要点

  • 114例高危皮肤鳞状细胞癌患者行前哨淋巴结活检,中位随访23.7个月。
  • 临床隐匿性前哨淋巴结转移与远处转移强相关(HR 10.7,95%CI 1.9-60.6)。
  • 前哨淋巴结转移患者远处转移阳性预测值为50%,7例前哨淋巴结阴性者仍发生远处转移。

核心结论

  • 作者认为前哨淋巴结活检不是评估高危皮肤鳞状细胞癌患者未来系统性癌细胞播散和远处转移风险的可靠诊断方法。

研究设计与样本

  • 前瞻性招募患者的双向性队列研究,2008年7月至2017年4月,139例 eligible 患者中114例接受前哨淋巴结活检(25例拒绝),中位随访23.7个月。

主要发现

  • 114例患者中男性89例(78.1%),女性25例(21.9%),中位年龄72.2岁。
  • 多变量分析中,组织病理学检出溃疡(HR 2.9,95%CI 0.7-12.2)、神经周围生长(HR 3.0,95%CI 0.6-14.6)和临床隐匿性前哨淋巴结转移(HR 10.7,95%CI 1.9-60.6)与未来发生远处转移强相关。
  • 前哨淋巴结转移被检出患者的远处转移阳性预测值为50%。
  • 7例组织病理学前哨淋巴结评估未见转移证据的患者仍发生远处转移。

临床怎么用

  • 作者认为前哨淋巴结活检不是评估高危皮肤鳞状细胞癌患者未来系统性播散和远处转移风险的可靠诊断方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most common cutaneous cancer worldwide. Several tumour characteristics are considered to pose an elevated risk for systemic spread of carcinoma cells ('high-risk' features). Early detection of subclinical metastases could permit early treatment and improve overall survival. To detect occult metastases and evaluate risk of future distant metastases, diagnostic extirpation of the sentinel lymph node (SLNE) is routinely performed in cutaneous melanoma and can be offered in high-risk cutaneous squamous cell carcinoma (hrcSCC). However, the clinical utility of SLNE in patients with hrcSCC remains unknown. MATERIAL AND METHODS: An ambidirectional cohort study with prospective patient recruitment was performed. Between July 2008 and April 2017, of 139 eligible patients, SLNE was performed in 114 cases (25 patients refused). Median follow-up was 23.7 months. RESULTS: We analysed the characteristics of 114 patients with hrcSCC who underwent SLNE. Eighty-nine patients (78.1%) were men, and 25 patients (21.9%) were women (median age 72.2 years). In multivariable analyses, histopathological detection of ulceration (hazard ratio, HR 2.9 [95% confidence interval, CI 0.7-12.2]), perineural growth (HR 3.0 [95% CI 0.6-14.6]) and clinically occult SLN metastases (HR 10.7 [95% CI 1.9-60.6]) were strongly associated with future occurrence of distant metastases. A positive predictive value of 50% was noted for patients where SLN metastasis was detected to develop distant metastases. However, distant metastases also occurred in seven patients when histopathological SLN evaluation had shown no evidence of metastases. CONCLUSIONS: Our data suggest SLNE is not a reliable diagnostic approach to evaluate the risk of future systemic carcinoma spread and development of distant metastases in patients with hrcSCC.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Jansen P, Petri M, Merz SF, et al. The prognostic value of sentinel lymph nodes on distant metastasis-free survival in patients with high-risk squamous cell carcinoma. Eur J Cancer. 2019. PMID: 30849684. doi:10.1016/j.ejca.2019.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。